The Scientist

» patent, evolution, immunology and disease/medicine

Most Recent

The National Institutes of Health is hosting a two-day conference on how the virus affects infants and children. The take-home message so far: microcephaly is but one of many potential problems for Zika-exposed fetuses.

0 Comments

image: How Plants Evolved Different Ways to Make Caffeine

How Plants Evolved Different Ways to Make Caffeine

By | September 21, 2016

Caffeine-producing plants use three different biochemical pathways and two different enzyme families to make the same molecule.

0 Comments

image: Further Support for Early-Life Allergen Exposure

Further Support for Early-Life Allergen Exposure

By | September 20, 2016

Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.

0 Comments

Scientists estimate the risk to fetuses exposed to the virus in utero.

0 Comments

Matching the immunological characteristics of donor retinal cells to those of the recipient can reduce the chance of rejection.

0 Comments

image: Stingrays Chew Too

Stingrays Chew Too

By | September 15, 2016

Researchers observe stingrays moving their jaws to grind up prey, a behavior thought to be restricted to mammals.

0 Comments

image: Neonatal Gut Bacteria Might Promote Asthma

Neonatal Gut Bacteria Might Promote Asthma

By | September 12, 2016

Byproducts of gut microbes in some 1-month–old babies trigger inflammation that is linked to later asthma development, researchers find.

0 Comments

image: Week in Review: September 5–9

Week in Review: September 5–9

By | September 9, 2016

Environmental magnetite in the human brain; prion structure takes shape; watching E. coli evolve in real time; learning from others’ behavior 

0 Comments

image: Giant Petri Dish Displays Evolution in Space and Time

Giant Petri Dish Displays Evolution in Space and Time

By | September 8, 2016

As E. coli bacteria spread over increasingly concentrated antibiotics, researchers discover novel evolutionary pathways that confer resistance.

6 Comments

image: Week in Review: August 29–September 2

Week in Review: August 29–September 2

By | September 2, 2016

Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech